May 31, 2016 6:40 PM ET

Pharmaceuticals

Company Overview of Neotropix, Inc.

Executive Profile

Charles M. Rudin M.D., Ph.D.

Member of Clinical Advisory Board, Neotropix, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background

Mr. Charles M. Rudin M.D., Ph.D. serves as a Sidney Kimmel Cancer Center Director of Lung Cancer Therapeutics Program. Dr. Rudin is Specialist in small cell lung cancer, novel oncology agent clinical trials and Lead investigator in virotherapy (Onyx-015) trials. He serves as a Member of Clinical Advisory Board for Neotropix, Inc. Although applicable to many malignancies, Dr. Rudin’s research focuses primarily on lung cancers and tumors of the upper aerodigestive tract. ...

Corporate Headquarters

351 Phoenixville Pike
Malvern, Pennsylvania 19355

United States

Phone: 610-296-8660
Fax: 610-296-8661

Board Members Memberships

There is no Board Members Memberships data available.

Education

PhD
The University of Chicago
PhD
Johns Hopkins University
MD
University Of Chicago - Pritzker School Of Medicine

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Neotropix, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.